Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations  to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading ->
New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading ->
US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading ->
Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer.  Ahead of the opening […] Continue reading ->
As Africa recorded its worst pandemic week, the COVAX Facility announced on Thursday that it has taken steps to quickly resume the delivery of vaccines to African countries including diversifying its portfolio of COVID-19 vaccines.  Aurélia Nguyen, Managing Director of the COVAX Facility based at Gavi, the Vaccine Alliance, said the COVAX portfolio now consists […] Continue reading ->
In his most explicit appeal to date, WHO’s Director General Dr Tedros Adhanom Ghebreyesus called upon the global leaders in COVID mRNA vaccine manufacturing – Pfizer/BioNTech and Moderna to “share their know-how” in vaccine manufacturing with more manufacturers, particularly in low- and middle-income countries.  The WHO DG also called upon countries that are beginning to […] Continue reading ->
In preparation for the next pandemic, the COVAX global vaccine facility “needs a pot of money, where they can be early movers” in competing for, and securing, vaccine doses. That could help scenarios like the ones seen recently, in which rich countries cornered the market on the first available COVID-19 vaccines, leading to severe shortages […] Continue reading ->